Reximmune-C™
Reximmune-C™ is currently being developed as a targeted and individualized vaccination of patients against their specific cancer. It combines Rexin-G™ with targeted vector bearing immune response genes that will work together to recruit the body's immune system to the site of cancer. Reximmune-C is designed to provide patients with a customized cancer vaccination that will evoke heightened anti-tumor immune response and prevent cancer recurrence.